INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA
Links shared publicly online about this topic.
- 1,771total visits
INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA
View full resource at medicalnewstoday.com
Tags: ADHD, ADHD Medication, Drug, Children's Health, FDA, Intuniv, Shire
Most Recently Shared on September 5, 2009 at 12:05 pm By:
INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA: Shire plc (L.. http://bit.ly/2IQcHz
FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on March 2, 2011 at 7:52 pm By:
FDA approves guanfacine ER tablets to treat ADHD in children, teens: FDA approved the use of once-daily gu... http://bit.ly/hRwbtM #adhd
FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatment of ADHD in children and adolescents - NeLM [2.1.9]
nelm.nhs.uk — “FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatment of ADHD in children and adolescents - NeLM [2.1.9]” View full resource at nelm.nhs.uk
Most Recently Shared on March 1, 2011 at 8:33 pm By:
FDA approves extended-release guanfacine (Intuniv®) as an adjunctive therapy to stimulants for the treatm... http://bit.ly/gF8pqX #adhd
PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
pharmalive.com — “PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents” View full resource at pharmalive.com
Most Recently Shared on February 28, 2011 at 7:27 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA OKs Wider Intuniv Use - http://tinyurl.com/4on7zsc
Intuniv gains indication as adjunctive therapy in ADHD - MPR
empr.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at empr.com
Most Recently Shared on February 28, 2011 at 3:44 pm By:
MPR News: Intuniv gains indication as adjunctive therapy in ADHD: Shire announced that the FDA has approved Intu... http://bit.ly/eyR7Gr
Intuniv gains indication as adjunctive therapy in ADHD - ONA
oncologynurseadvisor.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 28, 2011 at 3:40 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Intuniv gains indication as adjunctive therapy in ADHD http://goo.gl/fb/srbUs
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants
rttnews.com — “Shire plc (SHP.L, SHPGY) said that the US FDA approved the use of once-daily INTUNIV Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder, also known as ADHD, in children and adolescents ages 6 to 17 as part of a total treatment program.” View full resource at rttnews.com
Most Recently Shared on February 28, 2011 at 3:18 pm By:
Peter H Brown Doctor and Psychologist
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants http://bit.ly/dUc4ur #ADHD
Shire Announces FDA Approval of Once-Daily Intuniv (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
drugs.com — “Intuniv (guanfacine) is used to treat Attention-Deficit/Hyperactivity Disorder in children and adolescents aged 6 to 17 years. Includes Intuniv side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 4, 2009 at 12:32 am By:
FDA Approves Intuniv (guanfacine) for the Treatment of ADHD in Children and Adolescents - http://bit.ly/EObbC
Advertisement
